Comments
Loading...

ACADIA Pharmaceuticals

ACADNASDAQ
Logo brought to you by Benzinga Data
$16.42
0.090.55%
At Close: -
$16.42
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$42.00
Lowest Price Target1
$19.00
Consensus Price Target1
$27.09

ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock, Analyst Ratings, Price Targets, Forecasts

ACADIA Pharmaceuticals Inc has a consensus price target of $27.09 based on the ratings of 22 analysts. The high is $42 issued by Cantor Fitzgerald on August 22, 2023. The low is $19 issued by Oppenheimer on May 6, 2024. The 3 most-recent analyst ratings were released by Citigroup, UBS, and HC Wainwright & Co. on August 8, 2024, respectively. With an average price target of $24.33 between Citigroup, UBS, and HC Wainwright & Co., there's an implied 48.19% upside for ACADIA Pharmaceuticals Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
2
2
May
2
Jun
1
Jul
2
1
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.4
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Citigroup
UBS
HC Wainwright & Co.
Needham
Cantor Fitzgerald

1calculated from analyst ratings

Analyst Ratings for ACADIA Pharmaceuticals

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for ACADIA Pharmaceuticals (ACAD) stock?

A

The latest price target for ACADIA Pharmaceuticals (NASDAQ:ACAD) was reported by Citigroup on August 8, 2024. The analyst firm set a price target for $23.00 expecting ACAD to rise to within 12 months (a possible 40.07% upside). 61 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for ACADIA Pharmaceuticals (ACAD)?

A

The latest analyst rating for ACADIA Pharmaceuticals (NASDAQ:ACAD) was provided by Citigroup, and ACADIA Pharmaceuticals maintained their buy rating.

Q

When was the last upgrade for ACADIA Pharmaceuticals (ACAD)?

A

The last upgrade for ACADIA Pharmaceuticals Inc happened on January 24, 2024 when Needham raised their price target to $37. Needham previously had a hold for ACADIA Pharmaceuticals Inc.

Q

When was the last downgrade for ACADIA Pharmaceuticals (ACAD)?

A

The last downgrade for ACADIA Pharmaceuticals Inc happened on August 7, 2024 when Morgan Stanley changed their price target from $28 to $20 for ACADIA Pharmaceuticals Inc.

Q

When is the next analyst rating going to be posted or updated for ACADIA Pharmaceuticals (ACAD)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ACADIA Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ACADIA Pharmaceuticals was filed on August 8, 2024 so you should expect the next rating to be made available sometime around August 8, 2025.

Q

Is the Analyst Rating ACADIA Pharmaceuticals (ACAD) correct?

A

While ratings are subjective and will change, the latest ACADIA Pharmaceuticals (ACAD) rating was a maintained with a price target of $30.00 to $23.00. The current price ACADIA Pharmaceuticals (ACAD) is trading at is $16.42, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch